Want to join the conversation?
$AGN said its flagship Botox revenues rose 14% to $719.7MM in 2Q16 from last year, on continued market share expansion, enhanced promotional focus and overall continued strong demand for the product. Restasis revenue grew 20.2% to $390.6MM on continued strong promotional efforts. Fillers' revenues increased 14.7% $224.9MM.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.